Cardioxyl Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Cardioxyl Pharmaceuticals Ownership

Who owns Cardioxyl Pharmaceuticals?

Cardioxyl Pharmaceuticals is owned by Bristol-Myers Squibb. It was acquired on November 2, 2015.

Cardioxyl Pharmaceuticals Business Overview

Where is Cardioxyl Pharmaceuticals headquartered?

Cardioxyl Pharmaceuticals is headquartered in Chapel Hill, North Carolina.

What sector is Cardioxyl Pharmaceuticals in?

Cardioxyl Pharmaceuticals is a life science company.

When was Cardioxyl Pharmaceuticals founded?

Cardioxyl Pharmaceuticals was founded in 2005.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Cardioxyl Pharmaceuticals, Inc.

Exchange East Suite 212, 1450 Raleigh Road,
Chapel Hill, North Carolina 27517
United States,
(919) 869-8585
www.cardioxyl.com

Cardioxyl Pharmaceuticals, Inc. is a developer of novel therapeutic agents for the treatment of cardiovascular disease.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.